ArticlePediatric cardiology2026
National Trends and Disparities in Congenital Heart Disease Mortality in the United States, 1999-2024.
Article in Pediatric cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionCongenital heart disease (CHD) is the most prevalent birth defect, affecting nearly 1% of live births in the United States. Despite advances in diagnosis and treatment, CHD remains a major contributor to morbidity and mortality, with persistent demographic and regional disparities. This study examined national mortality trends and sociodemographic patterns in CHD-related deaths across the U.S. from 1999 to 2024.
methodsMortality data were extracted from the CDC WONDER Multiple Cause of Death database using ICD-10 codes Q20–Q26. Age-adjusted mortality rates (AAMRs) were calculated per 100,000 individuals using the 2000 U.S. standard population. Temporal trends were analyzed using Joinpoint regression to estimate annual percent changes (APC) and identify significant inflection points.
resultsA total of 120,626 CHD-related deaths were reported between 1999 and 2024. Infants accounted for the highest mortality (crude rate 54.2), with most deaths occurring in medical facilities (77%). National AAMR averaged 1.6 (95% CI: 1.3–2.0), declining significantly from 1999 to 2014 (APC − 2.6%) before increasing from 2014 to 2024 (APC + 1.2%). Mortality was higher among males, non-Hispanic Black, and American Indian/Alaska Native populations. Geographic disparities persisted, with higher rates in the Midwest and rural regions.
conclusionAfter years of improvement, CHD mortality in the U.S. has risen since 2014, highlighting persistent inequities tied to race, geography, and healthcare access. Targeted public health strategies are needed to strengthen adult CHD care networks, reduce structural disparities, and improve long-term outcomes.
Indexed as
Identifiers
41528440What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.